Newsbenzinga
EMA Says CHMP Has Recommended Granting A Marketing Authorisation In European Union For Rasonque (Daraxonrasib) For Metastatic Pancreatic Cancer
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…